These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16374202)

  • 1. Raising mean arterial pressure in patients with septic shock.
    Landoni G; Boroli F; D'Avolio S; Crivellari M
    Crit Care Med; 2006 Jan; 34(1):268-9; author reply 269. PubMed ID: 16374202
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimizing mean arterial pressure in septic shock: a critical reappraisal of the literature.
    Leone M; Asfar P; Radermacher P; Vincent JL; Martin C
    Crit Care; 2015 Mar; 19(1):101. PubMed ID: 25888071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of exogenous arginine vasopressin in the management of catecholamine-refractory septic shock.
    Lee CS
    Crit Care Nurse; 2006 Dec; 26(6):17-23. PubMed ID: 17123948
    [No Abstract]   [Full Text] [Related]  

  • 4. A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study.
    Kumar A; Safdar N; Kethireddy S; Chateau D
    Crit Care Med; 2010 Aug; 38(8):1651-64. PubMed ID: 20562695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study.
    Morelli A; Ertmer C; Lange M; Dünser M; Rehberg S; Van Aken H; Pietropaoli P; Westphal M
    Br J Anaesth; 2008 Apr; 100(4):494-503. PubMed ID: 18308741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediator modulation therapy of severe sepsis and septic shock: does it work?
    Phillip Dellinger R; Parrillo JE
    Crit Care Med; 2004 Jan; 32(1):282-6. PubMed ID: 14707593
    [No Abstract]   [Full Text] [Related]  

  • 7. Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial.
    Unger M; Morelli A; Singer M; Radermacher P; Rehberg S; Trimmel H; Joannidis M; Heinz G; Cerny V; Dostál P; Siebers C; Guarracino F; Pratesi F; Biancofiore G; Girardis M; Kadlecova P; Bouvet O; Zörer M; Grohmann-Izay B; Krejcy K; Klade C; Krumpl G
    Trials; 2018 Nov; 19(1):637. PubMed ID: 30454042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular management of septic shock.
    Pravinkumar E
    Crit Care Med; 2004 Jan; 32(1):315; author reply 315. PubMed ID: 14707616
    [No Abstract]   [Full Text] [Related]  

  • 9. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
    Benchekroune S; Karpati PC; Berton C; Nathan C; Mateo J; Chaara M; Riché F; Laisné MJ; Payen D; Mebazaa A
    J Trauma; 2008 May; 64(5):1188-95. PubMed ID: 18469640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norepinephrine in septic shock: when and how much?
    Hamzaoui O; Scheeren TWL; Teboul JL
    Curr Opin Crit Care; 2017 Aug; 23(4):342-347. PubMed ID: 28509668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intractable hypotension in septic shock: successful treatment with vasopressin in an infant.
    Leibovitch L; Efrati O; Vardi A; Matok I; Barzilay Z; Paret G
    Isr Med Assoc J; 2003 Aug; 5(8):596-8. PubMed ID: 12929303
    [No Abstract]   [Full Text] [Related]  

  • 12. Steroid therapy of septic shock: the decision is in the eye of the beholder.
    Dellinger RP
    Crit Care Med; 2008 Jun; 36(6):1987-9. PubMed ID: 18520670
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of vasopressin in septic shock.
    Ruggiero MS
    AACN Adv Crit Care; 2008; 19(3):281-7. PubMed ID: 18670203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin and the critically ill.
    Das UN
    Crit Care; 2002 Jun; 6(3):262-3. PubMed ID: 12133190
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of chronic hypertension on time to goal mean arterial pressure and clinical outcomes in critically ill patients with septic shock requiring vasopressors.
    Yeo QM; Hammond DA; Li C; Olsen KM
    J Crit Care; 2019 Feb; 49():143-148. PubMed ID: 30428412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of volume administration on Doppler-based renal resistive index, renal hemodynamics and renal function in medical intensive care unit patients with septic-induced acute kidney injury: a pilot study.
    Lahmer T; Rasch S; Schnappauf C; Schmid RM; Huber W
    Int Urol Nephrol; 2016 Aug; 48(8):1327-1334. PubMed ID: 27193438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressor dosing in septic shock.
    Alaniz C; Pollard S
    Crit Care Med; 2013 Dec; 41(12):e483-4. PubMed ID: 24275412
    [No Abstract]   [Full Text] [Related]  

  • 19. Vasopressin in septic shock: clinical equipoise mandates a time for restraint.
    Russell JA
    Crit Care Med; 2003 Nov; 31(11):2707-9. PubMed ID: 14605551
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted tissue perfusion versus macrocirculation-guided standard care in patients with septic shock (TARTARE-2S): study protocol and statistical analysis plan for a randomized controlled trial.
    Pettilä V; Merz T; Wilkman E; Perner A; Karlsson S; Lange T; Hästbacka J; Hjortrup PB; Kuitunen A; Jakob SM; Takala J
    Trials; 2016 Aug; 17():384. PubMed ID: 27484695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.